Summary
- Current Price
- As of today, RADX price is $4.30, down -0.92% on
- Current Price All-Time High
- RADX price is currently -91.54% below its historical high of $50.82 set on
- Market Cap
- RADX current market cap is $34M, down -9.42% year-over-year
- PE Ratio
- RADX PE ratio is unknown
- Revenue
- RADX current annual revenue is $2.35M, up +1099.95% year-over-year
- Next Earnings
- As of today, the next earnings release for RADX has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Radiopharm Theranostics Limited |
| Ticker | NASDAQ: RADX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Australia |
| IPO | |
| Indexes | Not included |
| Website | radiopharmtheranostics.com |
| Employees | - |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $4.30 | ||
| Price, 1D Change | -0.92% | |
| $34M | ||
| - | ||
| - | ||
| 0.41 | ||
| $2M | ||
| Revenue, 1Y Change | +1,099.95% | |
| -$3.43 | ||
| EPS, 1Y Change | +85.95% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$3.43 | ||
| EPS Estimate | N/A | -$3.29 |
| EPS Est. Change | N/A | +4.15% |
| $2.35M | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $4.30 | ||
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$6.24 | -$3.43 | +45.04% | |
| -$3.29 | N/A | +4.15% | |
| -$3.66 | N/A | -6.79% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.36M | $2.35M | +73.35% | |
| - | N/A | - | |
| $3.05M | N/A | +29.64% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -10.60% | ||
| - | ||
| -9.42% | ||
| - | ||
| +1,099.95% | ||
| +100.00% | ||
| +85.95% | ||
| +85.51% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $4.30 | ||
| $5.16 | ||
| SMA 200 vs Price | +20.01% | |
| $4.85 | ||
| SMA 50 vs Price | +12.74% | |
| 0.41 | ||
| $0.31 | ||
| 35.92 | ||
| 66.67% | ||
| 175.64% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $2.35M | ||
| -$3.43 | ||
| -$1.66M | ||
| -70.36% | ||
| -$28.50M | ||
| -1,211.24% | ||
| -$24.83M | ||
| -1,055.28% | ||
| -$26.82M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 2.67 | ||
| 2.67 | ||
| - | ||
| - | ||
| -2.92 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 1.02 | ||
| - | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $29.35M | ||
| $19.08M | ||
| $56.68M | ||
| $26.12M | ||
| $28.58M | ||
| $9.79M | ||
| $0.00 | ||
| $0.00 | ||
| $4.16M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $27.18M | ||
| $26.85M | ||
| $4.01M | ||
| $0.00 | ||
| $1.68M | ||
| $0.00 | ||
| $66.90K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$23.73M | ||
| $1.15M | ||
| $29.42M | ||
| $794.60K | ||
| -$24.53M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| B. Riley Securities | → | |
| B. Riley Securities | → | |
| Brookline Capital | ||
| Maxim Group | ||
| B. Riley Securities |
Analyst sentiment
Institutional ownership
Screeners with RADX
FAQ
What is the ticker symbol for Radiopharm Theranostics Limited?
The ticker symbol for Radiopharm Theranostics Limited is NASDAQ:RADX
Does Radiopharm Theranostics Limited pay dividends?
No, Radiopharm Theranostics Limited does not pay dividends
What sector is Radiopharm Theranostics Limited in?
Radiopharm Theranostics Limited is in the Healthcare sector
What industry is Radiopharm Theranostics Limited in?
Radiopharm Theranostics Limited is in the Biotechnology industry
What country is Radiopharm Theranostics Limited based in?
Radiopharm Theranostics Limited is headquartered in Australia
When did Radiopharm Theranostics Limited go public?
Radiopharm Theranostics Limited initial public offering (IPO) was on December 5, 2024
Is Radiopharm Theranostics Limited in the S&P 500?
No, Radiopharm Theranostics Limited is not included in the S&P 500 index
Is Radiopharm Theranostics Limited in the NASDAQ 100?
No, Radiopharm Theranostics Limited is not included in the NASDAQ 100 index
Is Radiopharm Theranostics Limited in the Dow Jones?
No, Radiopharm Theranostics Limited is not included in the Dow Jones index
When was Radiopharm Theranostics Limited last earnings report?
Radiopharm Theranostics Limited's most recent earnings report was on August 29, 2025
When does Radiopharm Theranostics Limited report earnings?
The date for Radiopharm Theranostics Limited's next earnings report has not been announced yet
Data Sources & References
- RADX Official Website www.radiopharmtheranostics.com
- RADX Profile on Yahoo Finance finance.yahoo.com/quote/RADX
- RADX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/radx